Mesyl Phosphoramidate Oligonucleotides as Potential Splice-Switching Agents: Impact of Backbone Structure on Activity and Intracellular Localization. (2021)
Attributed to:
Peptide conjugated oligonucleotides for a phase I/IIa clinical trial in Spinal Muscular Atrophy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1089/nat.2020.0860
PubMed Identifier: 33989066
Publication URI: http://europepmc.org/abstract/MED/33989066
Type: Journal Article/Review
Volume: 31
Parent Publication: Nucleic acid therapeutics
Issue: 3
ISSN: 2159-3337